Note: Ingredients listed on restricted chemical lists
EC/CAS
7647-01-0
Name of the chemical
Hydrochloric acid
Concentration
0.45 %
EC/CAS
1310-73-2
Name of the chemical
sodium hydroxide
Concentration
N/A
EC/CAS
7732-18-5
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
N/A
General Information
Version
0
Revision date
2018-08-16
Product name
0.45% Sodium Chloride Injection, USP
Product name
0.45% Sodium Chloride Injection, USP
Identification on the label/Trade name
0.45% Sodium Chloride Injection, USP | Manufacturer Fresenius Kabi Norge AS
Manufacturer Name
Fresenius Kabi Norge AS
Emergency telephone
+47-69-211100, +47-69-211101
Icons in SDS
Company Information
company name
Fresenius Kabi Norge AS
GHS Information
Signal word
DANGER
Hazard Codes
Hazard statements (CLP)
H314, H318, H335
Hazard statements
Code
Statements
H314
Causes severe skin burns and eye damage
Section 2
Signal word
DANGER. GHS Class Serious Eye Damage. category 1. Skin corrosion. category 1. Specific Target Organ Toxicity - STOT, Single Exposure SE. Category 3.
Hazard statements
Causes serious eye damage. Causes severe skin burns and eye damage. May cause respiratory irritation.
Precautionary statements
Do not breathe dust/fume/gas/mist/vapours/spray. Avoid breathing dust/fume/gas/mist/vapours/spray. Wash hands thoroughly after handling. Use only outdoors or in a well-ventilated area. Wear protective gloves/protective clothing/eye protection/face protection. IF SWALLOWED: Rinse mouth. Do not induce vomiting. IF ON SKIN (or hair): Remove/Take off immediately all contaminated clothing. Rinse skin with water/shower. IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing. IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a POISON CENTER or doctor/physician. Call a POISON CENTER or doctor/physician if you feel unwell. Specific treatment (see ... on this label). Wash contaminated clothing before reuse. Store in a well-ventilated place. Keep container tightly closed. Store locked up. Dispose of contents/container in accordance with Local, State, Federal and Provincial regulations. Emergency Overview This product is intended for therapeutic use only when prescribed by a physician. Potential adverse reactions from prescribed doses and overdoses are described in the package insert.
Principle Routes of Exposure
Inhalation Ingestion Eye contact Skin Absorption. Injection.
Potential health effects
Eye: Skin Contact with eyes may cause irritation. May cause skin irritation. Inhalation May cause irritation of respiratory tract. Ingestion May cause irritation. Signs/Symptoms Adverse reactions from prescribed doses include: febrile response, local tenderness, abscess, tissue necrosis, infection at injection site, venous thrombosis, phlebitis extending from the site of injection, and extravasation. Occupational exposure has not been fully investigated. Aggravation of Pre-Existing Individuals with hypernatremia or fluid retention. Conditions
